Preclinical Investigation of Goniotomy Using Four Different Techniques.
glaucoma
goniotomy
trabecular meshwork
Journal
Clinical ophthalmology (Auckland, N.Z.)
ISSN: 1177-5467
Titre abrégé: Clin Ophthalmol
Pays: New Zealand
ID NLM: 101321512
Informations de publication
Date de publication:
2020
2020
Historique:
received:
17
09
2020
accepted:
15
10
2020
entrez:
5
11
2020
pubmed:
6
11
2020
medline:
6
11
2020
Statut:
epublish
Résumé
To evaluate the tissue-level effects of goniotomy techniques on human trabecular meshwork (TM). Laboratory investigation. The TM from human cadaveric corneal rim tissue was treated using 4 techniques: (1) microvitreoretinal (MVR) blade; (2) 360° trabeculotomy with 5-0 prolene suture; (3) the Kahook Dual Blade (KDB) Glide The MVR blade exhibited incision of TM extending into the scleral wall. The TrabEx device removed a small portion of TM with large leaflet tissue remnants in all treated areas. 360° suture trabeculotomy resulted in incision of the TM proximate to Schwalbe's line with no excised tissue evident in all treated areas. Areas treated with the KDB Glide device resulted in nearly complete excision of TM without injury to surrounding tissues. The various methods used for performing goniotomy or trabeculotomy resulted in varying degrees of incision or excision of TM. Only the KDB Glide device resulted in reliable excision of TM with the other devices producing incision or variable excision of tissue. Clinical correlation is required to better understand the implications of the current findings when using these methods to lower intraocular pressure in eyes with glaucoma.
Identifiants
pubmed: 33149545
doi: 10.2147/OPTH.S281811
pii: 281811
pmc: PMC7604930
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3519-3525Informations de copyright
© 2020 Ammar et al.
Déclaration de conflit d'intérêts
DA Ammar has received financial support from New World Medical for contract work through his employer. Malik Kahook is a consultant to New World Medical, SpyGlass Ophthalmics and Alcon. He receives patent royalties from Alcon, New World Medical, Johnson and Johnson Vision, Fluent Ophthalmics, SpyGlass Ophthalmics, ShapeTech and Aurea Medical. He also reports a patent US10327947B2 with royalties paid by New World Medical. Leonard K Seibold is a consultant to New World Medical and reports grants from Glaukos and Allergan, outside the submitted work. The authors report no other conflicts of interest in this work.
Références
Am J Ophthalmol. 1953 Apr;36(4):445-53
pubmed: 13030655
Invest Ophthalmol Vis Sci. 1996 Jan;37(1):114-24
pubmed: 8550315
J Glaucoma. 2015 Apr-May;24(4):316-22
pubmed: 23807356
J Glaucoma. 2018 Jul;27(7):606-609
pubmed: 29965891
Ophthalmol Ther. 2019 Dec;8(4):549-561
pubmed: 31422555
Ophthalmology. 2014 Apr;121(4):855-61
pubmed: 24412282
Am J Ophthalmol. 2012 May;153(5):804-814.e1
pubmed: 22244522
Clin Ophthalmol. 2016 Jan 28;10:189-206
pubmed: 26869753
PLoS One. 2017 Aug 29;12(8):e0183142
pubmed: 28850575
Clin Ophthalmol. 2017 Aug 29;11:1583-1600
pubmed: 28919702
Am J Ophthalmol. 2013 Mar;155(3):524-529.e2
pubmed: 23218696
J Ophthalmol. 2017;2017:3182935
pubmed: 28512578
Am J Ophthalmol. 2007 Jan;143(1):23-31
pubmed: 17054896